Literature DB >> 7686019

Should further studies of chemotherapy be carried out in pancreatic cancer?

I Taylor.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 7686019     DOI: 10.1016/s0959-8049(05)80290-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  5 in total

Review 1.  Controversial issues in the management of pancreatic cancer: Part Two. A debate held at St Mary's Hospital, London on 18 November 1993.

Authors:  G Glazer; C Coulter; M E Crofton; W M Gedroyc; C D Johnson; C N Mallinson; R C Russell; M L Steer; J A Summerfield; R C Williamson
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

2.  A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Authors:  S Cascinu; R R Silva; S Barni; R Labianca; L Frontini; E Piazza; G Pancera; P Giordani; L Giuliodori; M A Pessi; V Fusco; G Luporini; R Cellerino; G Catalano
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

3.  Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Authors:  S Cascinu; L Frontini; G Comella; S Barni; R Labianca; N Battelli; R Casaretti; S Zonato; M Pirovano; G Catalano; R Cellerino
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

Review 4.  Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team.

Authors:  D D Von Hoff; A L Goodwin; L Garcia
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

5.  Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.

Authors:  T Shishido; T Yasoshima; R Denno; M Mukaiya; N Sato; K Hirata
Journal:  Jpn J Cancer Res       Date:  1998-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.